Susanne von Kroge

14PUBLICATIONS
31CO-AUTHORS
Haematological tumoursRadiation therapySocial epidemiologyRegenerative medicine (incl. stem cells)Other biomedical and clinical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 25, 2026
Insights into the survival impact of delayed immunochemotherapy in newly diagnosed diffuse large B-cell lymphoma: results from a nationwide registry study.

|Jul 29, 2025
Trophoblast Cell Surface Antigen 2 (Trop2) Is Expressed in Cases of EBV-Positive Diffuse Large B-Cell Lymphoma Emerging from Angioimmunoblastic T-Cell Lymphoma.

Susanne Ghandili, Judith Dierlamm, Carsten Bokemeyer

|Jan 08, 2025
Minimizing Long-Term Toxicities for Patients with Primary Mediastinal B-Cell Lymphoma Undergoing Modern Radiotherapy: Results from a Monocentric Biophysical Risk Evaluation.

Andrea Baehr, Sebastian Schäfer, Maria Jäckel

|Oct 11, 2024
A German perspective on the impact of socioeconomic status in diffuse large B-cell lymphoma.

Susanne Ghandili, Judith Dierlamm, Carsten Bokemeyer

|Sep 28, 2023
EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma.

Nuray Akyüz, Snjezana Janjetovic, Susanne Ghandili

|Nov 16, 2022
VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience.

Susanne Ghandili, Dzenefa Alihodzic, Christian Wiessner

Pageof 3

Frequent Collaborators

3 joint publications

Franziska Modemann

3 joint publications

Walter Fiedler

2 joint publications

Martin Schönlein

2 joint publications

Lisa B Leypoldt